Fatal trichoderma harzianum infection in a leukemic pediatric patient

Medical Mycology

Volumn 47, Issue 2, 2009, Pages 207-215

  Kantarcioglu, A Serda ^a   Celkan, Tiraje ^a   Yucel, Ayhan ^a   Mikami, Yuzuru ^b   Kurugoglu, Sebuh ^a   Mitani, Hiroki ^b   Altas, Kemal ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Fungal infections in leukemic patients; Mycoses in pediatric patients; Trichoderma antifungal susceptibility; Trichoderma harzianum; Trichoderma human infection

Indexed keywords

ANTIFUNGAL AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIFUNGAL RESISTANCE; ARTICLE; CASE REPORT; CHILD; CLASSIFICATION; DRUG EFFECT; FATALITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LATEX AGGLUTINATION TEST; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; TRICHODERMA;

ANTIFUNGAL AGENTS; CHILD; DRUG RESISTANCE, FUNGAL; FATAL OUTCOME; HUMANS; LATEX FIXATION TESTS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOSES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRICHODERMA;

EID: 79958165576     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802406225     Document Type: Article

References (52)

1. De Hoog GS, Guarro J, Géne JL, Figueras MJ. Atlas of Clinical Fungi, 2nd ed. Centraalbureau voor Schimmelcultures: Universitat Rovira i Virgilli, Utrecht/Reus, 2000: 943
2. Summerbell RC. Ascomycetes: Aspergillus, Fusarium, Sporothrix, Piedra, and relatives. In: Howard DH (ed.). Pathogenic Fungi in Humans and Animals. NewYork: Marcel Dekker, Inc, 2003: 437-449
3. Tamura S, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: Analysis reveals a new genotype of C. albicans with group 1 intron. J Clin Microbiol 2001; 39: 4309-4315 (Pubitemid 33117115)
4. National Committee for Clinical Laboratory Standards. 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved standard. NCCLS document M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA
5. Espinel-Ingroff A, Chaturvedi V, Fothergill A, Rinaldi M. Optimal testing conditions for determining MICs and minimal fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol 2002; 40: 3776-3781
6. Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol 2001; 39: 91-95 (Pubitemid 32192922)
7. Espinel-Ingroff A, Bartlett M, Chaturvedi V, et al. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp: NCCLS collaborative evaluation. Antimicrob Agents Chemother 2001; 45: 1828-1835 (Pubitemid 32466356)
8. Druzhinina I, Kubicek CP. Species concepts and biodiversity in Trichoderma and Hypocrea: from aggregate species to species clusters? J Zhejiang Univ SCI 2005; 6B: 100-112 (Pubitemid 40232918)
9. Trichoderma and Hypocrea. Fungal Genet Biol 2005; 42: 813-828
10. Kopchinskily A, Komon M, Kubicek CP, Druzhinina IS. Tricho-BLAST: a multilocus database for Trichoderma and Hypocrea identifications. Mycol Res 2005; 109: 657-660
11. Walsh TJ, GrolL A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10(Suppl. 1): 48-66 (Pubitemid 38379951)
12. Gonzales R, Gomez P, Gonzales R, et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect 2005; 53: 33-37 (Pubitemid 41337996)
13. Robertson MH. Fungi in fluids-A hazard of intravenous therapy. J Med Microbiol 1970; 3: 99-102
14. Escudero G, Pino C, Munoz R. Micoma pulmonar causado por Trichoderma viride. Actas Dermo-Sifiliograficas 1976; 67: 673-680
15. Seguin P, Degeilh B, Grulois I, et al. Successful treatment of a brain abscess due to Trichoderma longibrachiatum after surgical resection. Eur J Clin Microbiol Infect Dis 1995; 14: 445-448
16. Gautheret A, Dromer F, Bourhis JH, Andremont A. Trichoderma pseudokoningii as a cause of fatal infection in a bone marrow transplant recipient. Clin Infect Dis 1995; 20: 1063-1064
17. Guarro J, Antolin-Ayala MI, Gené J, et al. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol 1999; 37: 3751-3755 (Pubitemid 29491133)
18. Richter S, Cormican MG, Pfaller MA, et al. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol 1999; 37: 1154-1160 (Pubitemid 29140629)
19. Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002; 35: 1360-1367 (Pubitemid 35448964)
20. Esel D, Koc AN, Utas C, Karaca N, Bozdemir N. Fatal peritonitis due to Trichoderma spp. in a patient undergoing continuous ambulatory peritoneal dialysis. Mycoses 2003; 46: 71-73 (Pubitemid 36278906)
21. Kredics L, Antal Z, Manczinger L, et al. Clinical importance of the genus Trichoderma-A review. Acta Microbiol Immunol Hung 2003; 50: 105-117 (Pubitemid 39178453)
22. Guiserix J, Ramdane M, Finielz P, Michault A, Rajaonarivelo P. Trichoderma harzianum peritonitis in peritoneal dialysis. Nephron 1996; 74: 473-474 (Pubitemid 26326742)
23. Antal Z, Varga JN, Kredics L, et al. Intraspecific mitochondrial DNA polymorphism within the emerging filamentous fungal pathogen Trichoderma longibrachiatum. J Med Microbiol 2006; 55: 31-35 (Pubitemid 43031235)
24. Kredics L, Antal Z, Szekeres A, et al. Production of extracellular proteases by human pathogenic Trichoderma longibrachiatum strains. Acta Microbiol Immunol Hung 2004; 51: 283-295 (Pubitemid 39531638)
25. Benitez T, Rincon AM, Limon MC, Codon AC. Biocontrol mechanisms of Trichoderma strains. Inter Microbiol 2004; 7: 249-260 (Pubitemid 43126708)
26. Antal Z, Kredics L, Doczi I, et al. The physiological features of opportunistic Trichoderma strains. Acta Microbiol Immunol Hung 2002; 49: 393
27. Kuhls K, Lieckfeldt E, Börner T, Gueho E. Molecular reidentification of human pathogenic Trichoderma isolates as Trichoderma longibrachiatum and Trichoderma citrinoviride. Med Mycol 1999; 37: 25-33 (Pubitemid 29110241)
28. Antal Z, Kredics L, Pakarinen J, et al. Comparative study of potential virulence factors in human pathogenic and saprophytic Trichoderma longibrachiatum strains. Acta Microbiol Immunol Hung 2005; 52: 341-450
29. Szekeres A, Laday M, Kredics L, et al. Rapid identification of clinical Trichoderma longibrachiatum isolates by cellulose-acetate electrophoresis mediated isoenzyme analysis. Clin Microbiol Infect 2006; 12: 369-375 (Pubitemid 43337527)
30. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14 (Pubitemid 33152659)
31. Kami M, Machida U, Okuzumi K, et al. Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy. Br J Haematol 2002; 117: 40-46 (Pubitemid 34304419)
32. Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 2004; 10: 922-925 (Pubitemid 39405841)
33. Ellepola AN, Morrison JC. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005; 43: 65-84 (Pubitemid 40431503)
34. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995; 20: 598-605
35. Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 1984; 105: 616-622 (Pubitemid 14003580)
36. Friedman S, Richardson SE, Jacobs SE, O'Brien K. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 2000; 19: 499-504 (Pubitemid 30409474)
37. Noyola DE, Fernandez M, Moylett EH, Baker CJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001; 32: 1018-1023 (Pubitemid 32299636)
38. Benjamin DK Jr, Ross K, McKinney RE Jr, et al.When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulasenegative streptococcal bacteremia. Pediatrics 2000; 106: 712-718
39. Munoz FM, Demmler GJ, Travis WR, et al. Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia. J Clin Microbiol 1997; 35: 499-503 (Pubitemid 27043934)
40. Tang P, Mohan S, Sigler L, et al. Allergic fungal sinusitis associated with Trichoderma longibrachiatum. J Clin Microbiol 2003; 41: 5333-5336 (Pubitemid 37429974)
41. Varo SD, Martins CHG, Cardoso MJO, et al. Isolamento de fungos filamentosos em agua utilizada em uma unidade de hemodialise. Rev Soc Brasil Med Trop 2007; 40: 326-331 (Pubitemid 47122452)
42. Hageskal G, Knutsen AK, Gaustad P, de Hoog GS, Skaar I. Diversity and significance of mold species in Norwegian drinking water. Appl Environ Microbiol 2006; 72: 7586-7593 (Pubitemid 44927660)
43. Ribeiro A, Machado AP, Kozakiewicz Z, et al. Fungi in bottled water: a case study of a production plant. Rev Iberoam Mycol 2006; 23: 139-144 (Pubitemid 44735333)
44. Madsen AM, Hansen VM, Meyling NV, Eilenberg J. Human exposure to airborne fungi from genera used as biocontrol agents in plant production. Ann Agric Environ Med 2007; 14: 5-24 (Pubitemid 47035651)
45. Abdel Hameed AA, Yasser IH, Khoder IM. Indoor air quality during renovation actions: a case study. J Environ Monit 2004; 6: 740-744 (Pubitemid 39312408)
46. Myoken Y, Sugata T, Fujita Y, et al. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. Int J Oral Maxillofarc Surg 2002; 31: 688-691
47. Pujol I, Guarro J, Llop C, Soler L, Fernandez-Ballart J. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother 1996; 40: 2106-2110 (Pubitemid 26296255)
48. Kratzer C, Tobudic S, Schmoll M, Graninger W, Georgopoulos A. In vitro activity and synergism of amphotericin B, azoles and cationic microbials against the emerging pathogen Trichoderma spp. J Antimirob Chemother 2006; 58: 1058-1061
49. Tobudic S, Schmoll M, Graninger W, Georgopoulos A. In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp. J Antimicrob Chemother 2006; 58: 1058-1106
50. Marco F, Pfaller MA, Messer SA, Jones RN. In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi. Mycopathologia 1998; 141: 73-77 (Pubitemid 28407946)
51. Espinel-Ingroff A. Comparison of E test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic fungi. J Clin Microbiol 2001; 39: 1360-1367 (Pubitemid 32275436)
52. Furukawa H, Kusne S, Sutton DA, et al. Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 1998; 26: 487-489. (Pubitemid 28083967)